Eculizumab concentration-time profiles in patients with TA-TMA, with or without bleeding complications. The y-axis shows observed concentrations of eculizumab, and the x-axis shows time after each dose. The black circles represent the data for nonbleeding patients (n = 38) and the red circles represent the data for bleeding patients (n = 19). The data collected from the same patients are connected by dotted lines.